RevMed

Alere Scarborough, Inc. D1300 Alere NMP22 BladderChek Test

Company Name
Alere Scarborough, Inc.
Catalog Number
D1300

Description

The Alere NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
Have questions or need more information? Contact Us

Pricing
Summary

Price Not Available
Out of Stock
Interested in this product?
Contact us or login to add to your watchlist.

Related Items

Additional Details

Device Identifier
10811877010774
Is RX
Yes
Is Over the Counter
No
Requires Sterilization
No
Is Sterile
No
Is Single Use
Yes

Barcode Mapping

Unit of MeasurementEachesGTIN
Each110811877010774